JP6912379B2 - インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物 - Google Patents

インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物 Download PDF

Info

Publication number
JP6912379B2
JP6912379B2 JP2017533018A JP2017533018A JP6912379B2 JP 6912379 B2 JP6912379 B2 JP 6912379B2 JP 2017533018 A JP2017533018 A JP 2017533018A JP 2017533018 A JP2017533018 A JP 2017533018A JP 6912379 B2 JP6912379 B2 JP 6912379B2
Authority
JP
Japan
Prior art keywords
amino acid
seq
pharmaceutical composition
composition according
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017533018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018505861A (ja
JP2018505861A5 (enExample
Inventor
シラール，ジャン−クロード
カルノイ，クリストフ
トロタン，フランソワ
ポルテ，レミ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Publication of JP2018505861A publication Critical patent/JP2018505861A/ja
Publication of JP2018505861A5 publication Critical patent/JP2018505861A5/ja
Application granted granted Critical
Publication of JP6912379B2 publication Critical patent/JP6912379B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP2017533018A 2014-12-23 2015-12-22 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物 Active JP6912379B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14307154.6 2014-12-23
EP14307154 2014-12-23
PCT/EP2015/080924 WO2016102536A1 (en) 2014-12-23 2015-12-22 Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020033407A Division JP2020138968A (ja) 2014-12-23 2020-02-28 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物

Publications (3)

Publication Number Publication Date
JP2018505861A JP2018505861A (ja) 2018-03-01
JP2018505861A5 JP2018505861A5 (enExample) 2018-10-25
JP6912379B2 true JP6912379B2 (ja) 2021-08-04

Family

ID=52432622

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017533018A Active JP6912379B2 (ja) 2014-12-23 2015-12-22 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物
JP2020033407A Pending JP2020138968A (ja) 2014-12-23 2020-02-28 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020033407A Pending JP2020138968A (ja) 2014-12-23 2020-02-28 インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物

Country Status (5)

Country Link
US (1) US10736937B2 (enExample)
EP (1) EP3236988B8 (enExample)
JP (2) JP6912379B2 (enExample)
ES (1) ES2809598T3 (enExample)
WO (1) WO2016102536A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA52545B1 (fr) * 2018-04-16 2024-08-30 F. Hoffmann-La Roche Ag Anticorps pour radionucléides chélatés
FR3114970B1 (fr) 2020-10-08 2023-06-30 Univ Tours Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires
KR20240027752A (ko) 2021-06-30 2024-03-04 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 플라겔린의 폐 전달을 위한 에어로졸 조성물
WO2025172452A1 (en) 2024-02-14 2025-08-21 Institut National de la Santé et de la Recherche Médicale Combination for treating bacterial infection due to pseudomonas aeruginosa antibiotic-resistant strain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2300609T3 (da) * 2008-06-25 2014-02-10 Inst Nat Sante Rech Med Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf
EP2585094B1 (en) * 2010-06-25 2018-08-01 INSERM - Institut National de la Santé et de la Recherche Médicale Flagellin polypeptide as tlr5 agonist for use in the treatment of respiratory tract infections
EP2903622A1 (en) 2012-10-03 2015-08-12 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
US20150246095A1 (en) 2012-10-03 2015-09-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza
JP6274904B2 (ja) * 2014-02-25 2018-02-07 キヤノン株式会社 固体撮像装置及び撮像システム

Also Published As

Publication number Publication date
JP2018505861A (ja) 2018-03-01
EP3236988A1 (en) 2017-11-01
EP3236988B8 (en) 2020-08-19
WO2016102536A1 (en) 2016-06-30
US20180264077A1 (en) 2018-09-20
JP2020138968A (ja) 2020-09-03
EP3236988B1 (en) 2020-06-24
ES2809598T3 (es) 2021-03-04
US10736937B2 (en) 2020-08-11

Similar Documents

Publication Publication Date Title
JP2020138968A (ja) インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物
EP3302492B1 (en) Halogenated salicylanilides for treating clostridium infections
US8916542B2 (en) Chitosan derivatives, compositions and related methods of use
Bryskier Bacillus anthracis and antibacterial agents
AU2013288416B2 (en) Colicins for treating bacterial infections
JP5782615B2 (ja) オリタバンシンの単回用量を用いる治療の方法
US11560543B2 (en) Genetically engineered microorganisms and methods of use
Tonnaer et al. Advances in understanding the pathogenesis of pneumococcal otitis media
WO2023275292A2 (en) Aerosol composition for pulmonary delivery of flagellin
US20180344807A1 (en) Methods and pharmaceutical compositions for the treatment of acute exacerbations of chronic obstructive pulmonary disease
US20220218787A1 (en) Genetically engineered microorganisms and methods of use
US20210332095A1 (en) Infection-induced endothelial amyloid compositions as antimicrobials
WO2025172452A1 (en) Combination for treating bacterial infection due to pseudomonas aeruginosa antibiotic-resistant strain
US20220031803A1 (en) Antibacterial composition comprising microcin s and antibiotic
US20220160857A1 (en) Multivalent vaccines derived from klebsiella out membrane proteins
Craft et al. Systemic antimicrobial therapy
CN118697765A (zh) 铂类抗癌药物的新用途
Tonnaer et al. Factors contributing to the pathogenesis of otitis media, with emphasis on pneumococci
US20180280321A1 (en) Compositions and methods that inhibit quorum sensing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180914

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180914

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190917

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20191029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200228

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20200228

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200228

C12 Written invitation by the commissioner to file intermediate amendments

Free format text: JAPANESE INTERMEDIATE CODE: C12

Effective date: 20200331

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20200721

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20200728

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20200821

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20200825

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20201208

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20210119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210416

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210511

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210608

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210608

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210708

R150 Certificate of patent or registration of utility model

Ref document number: 6912379

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250